Shukra Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 246.38 million compared to INR 37.21 million a year ago. Revenue was INR 248.81 million compared to INR 37.49 million a year ago. Net income was INR 47.09 million compared to INR 0.764 million a year ago.
For the six months, sales was INR 447.98 million compared to INR 102.86 million a year ago. Revenue was INR 456.75 million compared to INR 103.23 million a year ago. Net income was INR 51.3 million compared to INR 4.04 million a year ago.